Oxford, UK – 08 November 2018. OGT, The Molecular Genetics Company, has announced that it has expanded its direct sales of CytoCell Fluorescence In Situ Hybridisation (FISH) products to include the Asia-Pacific (APAC) region. OGT will provide customers in Singapore, Malaysia, Vietnam, Australia, and New Zealand with enhanced local sales and support services via established affiliates of Sysmex Corporation, as well as via continued collaboration with existing distributors. The move follows the successful introduction of selling via a number of European Sysmex affiliates earlier this year.
OGT’s CytoCell brand is well-known for providing the widest range of high-quality, reliable, and cost-effective FISH probes on the market, as well as excellent customer support, service, and expertise. To grow and maintain its renowned exceptional customer support services on a global scale, OGT is also delivering extensive training programmes across the portfolio for Sysmex staff in EMEA and APAC.
In addition to the expansion into APAC, OGT is increasing its global logistics cooperation with Sysmex, providing customers with extra levels of support and convenience. The company has recently opened a new CytoCell customer service and distribution centre, initially for customers in the USA, located in Lincolnshire, IL, at the Sysmex America, Inc. (SAI) Headquarters. By working closely with SAI, OGT will be able to deliver extended ordering and shipping hours, and plans to establish a Singapore distribution centre to serve customers in APAC in the future.
Spencer Howell, Executive VP Sales at OGT, remarked, “Building on the successes of previous initiatives to establish direct sales through Sysmex affiliates, which have provided many benefits to customers in Poland, Czechia, Slovakia, France, Belgium, Switzerland and Luxembourg, we are now focusing on APAC where we see enormous growth potential. With increased local support and activity, backed by larger Sysmex affiliate organisations, we will increase our visibility, deliver growth, and be able to better realise the opportunities. The expanding cooperation with Sysmex delivers the benefits of being part of a larger organisation to our customers, providing them with enhanced local service and support, something we are committed to continue developing.”
OGT, a Sysmex Group company, is a leading global provider of clinical and diagnostic genomic solutions that are created for scientists by scientists - including CytoCell®, CytoSure® and SureSeq™ ranges of FISH, microarray and NGS products. The company is dedicated to creating products that enable researchers and clinical decision makers to reach the right care decisions for each patient, every time. OGT strives to unlock the future of genetic clinical care with a commitment to working in partnership with its customers - not only by sharing its expertise of 25 years at the forefront of genetic endeavour, but also by working closely with scientists to understand their unique challenges, and to customise its approach to meet their exact needs. Dedicated to improving clinical care, OGT believes that through partnership—together—we’ll achieve more.
For more information on the Company, please visit our website at ogt.com
CytoSure®, SureSeq™ and myProbes®: For Research Use Only, not for use in diagnostic procedures. CytoCell: Some products may not be available in your region.
About Sysmex Corporation
Sysmex Corporation is a world leader in clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. Serving customers for more than 50 years, Sysmex focuses on technological leadership in diagnostic science and information tools that make a difference in the health of people worldwide. The company is also exploring emerging opportunities in the life science field. Its R&D efforts focus on the development of high-value-added testing and diagnostic technologies that are innovative, original and optimize individual health. Sysmex also seeks to leverage its state-of-the-art technologies for cell, gene and protein analysis. The company, headquartered in Kobe, Japan, has subsidiaries in North America, Latin America, Europe, the Middle East, Africa, China and Asia Pacific and employs more than 9,000 employees worldwide. Sysmex Corporation is listed in the top tier of the Tokyo Stock Exchange.
For more information about Sysmex Corporation and its affiliate companies, please visit www.sysmex.co.jp/en/.
Sysmex demonstrates confidence and investment in OGT and the United Kingdom.Read
Addition of direct-sales territories follows successes across Europe and APAC and provides customers with enhanced local sales and support services.Read
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden.Read